Q fever is a worldwide zoonosis caused by Coxiella burnetii, a small gram-negative coccobacillus. Transmission usually occurs by inhalation of infected aerosolized particles carried by the wind or by direct contact with infected animal products, especially from cattle. Q fever occurs in acute and chronic forms [1] . Acute Q fever is usually a self-limited disease with 3 main clinical presentations: nonspecific flulike illness, acute hepatitis, and pneumonia occasionally leading to a lethal respiratory distress syndrome [2] . Pregnant women, patients with valvular disease or prosthetic grafts, and immunocompromised patients are at risk of developing the chronic form with infection of heart valves, vascular aneurysms, or prostheses. Q fever was first described in 1935 as an outbreak of febrile illness among abattoir workers in Brisbane, Australia [3] . Since then, it has been reported almost worldwide, particularly in southern France, the United Kingdom, Italy, Spain, Germany, Israel, Greece, Japan, Canada, and the Netherlands. Coxiella burnetii infection is probably underestimated in many countries, especially in developing countries, probably because of a lack of screening. Human Q fever has been less well described in South America (specifically Uruguay, Mexico, Peru, Argentina, Suriname, and Brazil), where few cases of the chronic form have been reported [4] [5] [6] [7] [8] [9] [10] [11] [12] . The epidemiology of Q fever has not been fully elucidated in French Guiana, a French overseas region located on the northeastern coast of South America. About 90% of its surface of 84 000 km 2 is covered by the Amazonian rain forest; the remaining 10%, located in the north, consists of a coastal plain where 90% of the 215 000 inhabitants live. The main city, Cayenne, contained almost half of the region's population in 2009. Q fever was first described in 1955 in French Guiana in a serologic study conducted in slaughterhouse workers in Cayenne [13] . Sporadic cases were then reported until 1996 when 3 patients were hospitalized in the intensive care unit of the Cayenne Hospital for acute respiratory distress syndrome, leading to 1 death [14] . At the same time, many benign cases were diagnosed in the general population. A retrospective serologic study performed from 1992 to 1996 showed an increase in the annual incidence in 1996, which was estimated to be 37 per 100 000 inhabitants. The reasons for this increase in incidence were unclear; no link with classic sources of infection (cattle, sheep, or goat birth products) could be found [15] . Pneumonia is the major manifestation of acute Q fever diagnosed in French Guiana but the frequency of C. burnetii among pneumonia pathogens is unknown. Because Legionella pneumophila infection is very rare in French Guiana, the empirical community-acquired pneumonia (CAP) antibiotherapy in French Guiana combines amoxicillin and doxycycline to target both C. burnetii and Streptococcus pneumoniae. Because of growing concerns about antimicrobial resistance and adverse effects of antibiotherapy, we searched for a prediction rule to identify patients at low risk of Q fever pneumonia in order to guide the choice of first-line antibiotherapy for the treatment of CAP in French Guiana. Our objectives were (1) to describe the prevalence of Q fever among inpatients with CAP, (2) to identify clinical or biological factors associated with Q fever pneumonia, and (3) to build a predictive score for the screening of patients with Q fever pneumonia.
METHODS

Study Design
We carried out a retrospective case-control study to explore the factors associated with acute Q fever among a historical cohort of inpatients admitted with CAP to the Department of 
Inclusion Criteria and Case Definition
All consecutive patients who had an acute onset of cough, a body temperature >38°C, clinical signs suggestive of pneumonia, and radiographic evidence of pneumonia were considered to have CAP. Serodiagnosis of Q fever was performed on all patients with CAP using immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies against phase II (acute infection) and phase I (chronic infection) antigens of C. burnetii in an indirect immunofluorescence assay [16] . Screening serologic tests were performed at the Institut Pasteur de la Guyane, and phase diagnoses were made by the French National Reference Center for Rickettsial Diseases, Marseille. A single serum sample of phase II antibody titers with IgG titers ≥1:200 and IgM titers ≥1:50 or seroconversion with a 4-fold increase in phase II antibody titers was considered diagnostic of acute Q fever. Patients were considered seronegative for Q fever when IgM titers were <1:25 and IgG titers were <1:50. Diagnostic tests for other pneumonia pathogens were performed. Serologic tests were used to detect Mycoplasma pneumoniae, Chlamydia pneumoniae, Chlamydia psittaci, and L. pneumophila. The identification of L. pneumophila and S. pneumoniae was based on the detection of specific antigens in urine samples by an immunochromatographic assay and blood cultures. If pulmonary tuberculosis was suspected, specific direct examination and cultures of sputum smears were performed. Patients with Q fever pneumonia were considered case patients, and patients with CAP who tested seronegative for Q fever were considered controls.
A standardized form was completed retrospectively for data collection, including socioepidemiologic data, clinical symptoms, and radiographic and biological results. All data were recorded retrospectively with Epi Info software, version 3.5.1.
Ethics Statement
Patients' medical records were retrospectively reviewed, and all data collected were anonymized in standardized forms according to procedures of the Commission Nationale de l'Informatique et des Libertés (the French information protection commission).
Statistical Analysis
Categorical variables were summarized using percentages and compared using Fisher exact test. Continuous variables were summarized using means ± standard deviations or medians with interquartile ranges and compared using the MannWhitney test. Potential predictors for the occurrence of Q fever pneumonia were investigated using bivariate logistic regression. Variables with >10% missing data were a priori excluded from multivariate analysis. All promising variables with a P value of <.20 in the bivariate analysis were entered into a multivariate logistic regression with a backward approach; the significance level was set at P < .05. Adjusted odds ratios (ORs) are presented with 95% confidence intervals (CIs).
Model comparisons were performed using the likelihood ratio (LR) test.
Predictive Score
All significant variables of the logistic model were used to determine a preliminary prognostic score of Q fever pneumonia. To improve model stability and because of the small sample size, a semi-external validation was performed using a .632 bootstrap procedure [17] . In brief, 1000 training and testing samples were generated. Medians and interquartile ranges of each β coefficient obtained from regression over the training samples were then reported. To assess the goodness-of-fit model, the C statistic (area under the receiver operating characteristic curve) and its 95% CI were computed. Median β coefficients from the bootstrap procedure were then rounded to construct integer weights for each variable. The assigned weights were then summed to compute that patient's score. Intrinsic (sensibility, specificity, accuracy) and extrinsic ( positive and negative predictive value, positive and negative LR) qualities of the score were then assessed using a classic bootstrap procedure. All analyses were performed using R software, version 2.13.0, and Stata 11.0 software (StataCorp).
RESULTS
Baseline Characteristics
From 1 May 2004 to 31 September 2007, 131 consecutive patients with CAP were included in the study. Ninety-two (70.2%) were males and 38 (29.0%) had comorbid conditions. The mean age was 45.9 years (range, 15-90 years) and the average time between the onset of symptoms and admission was 5.7 days (Table 1) . A microbiological etiologic agent was identified for 60 patients (45.8%): C. burnetii (n = 32) was the most frequent, followed by Mycobacterium tuberculosis (n = 5) and Pneumocystis jirovecii in human immunodeficiency virusinfected patients (n = 5). Mycoplasma pneumoniae (n = 3) and S. pneumoniae (n = 2) were less frequently identified in this study.
Prevalence and Characteristics of Q Fever Pneumonia
The prevalence of Q fever pneumonia was 24.4% (95% CI, 17.1-31.8) among the 131 CAP cases studied. All Q fever cases were diagnosed by seroconversion between paired blood samples. The mean age of patients with Q fever pneumonia was 46.5 years and did not differ significantly from that of controls. The prevalence of comorbid conditions was significantly lower (12.5%) in patients with Q fever pneumonia than in controls (46.5%) ( Table 1 ). The clinical picture of Q fever pneumonia was more severe overall, with frequent chills, night sweats, and a more marked pain syndrome with headache and arthromyalgia (P < .05) ( Table 2 ). However, the frequencies of a body temperature >38.5°C and respiratory symptoms (dyspnea, chest pain) did not differ significantly from those seen in non-Q fever pneumonia. Pulmonary auscultation and chest radiographic signs did not differ significantly between the 2 groups.
Blood tests revealed that patients with Q fever pneumonia had significantly higher C-reactive protein (CRP) levels (>185 mg/L) and most of them (87.1%) had normal or low leukocyte counts (<10 × 10 9 /L) compared with controls (P < .001) Abbreviations: CAP, community-acquired pneumonia; HIV, human immunodeficiency virus; NS, not significant; SD, standard deviation. a For comparison between Q fever CAP and non-Q fever CAP. The significance level was set at P < .05.
( Table 2 ). However, there were no differences between the 2 groups concerning lymphocyte count, platelet count, or liver enzyme levels. The clinical outcome was benign for all patients with Q fever pneumonia except for one 50-year-old patient who was admitted to the intensive care unit for acute respiratory distress syndrome but survived.
Risk Factors and Prognostic Score of Q Fever Pneumonia
In multivariate logistic regression analyses, male sex (OR, 4. Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CAP, community-acquired pneumonia; CRP, C-reactive protein; GGT, γ-glutamyl transferase; IQR, interquartile range; NS, not significant; pO2, partial pressure of oxygen; SD, standard deviation. a For comparison between Q fever CAP and non-Q fever CAP. Significance level was set at P < .05.
After 1000 resampling iterations using a .632 bootstrap procedure, median β coefficients of prognostic factors (sex, age, headache, leukocyte count, and CRP level) were estimated. The median area under the curve was equal to 0.83 (95% CI, .72-.90), which indicates good model discrimination.
The construction of the score is detailed in Table 3 . The median β coefficients of sex, age, headache, leukocyte count, and CRP level were rounded to build corresponding weights. Except for CRP level, the median β coefficient of each prognostic factor was rerounded to a weight of +2. For CRP level, the estimation of the median was close to 1.5. According to the distribution of estimates, +1 was chosen for the value of the weight (data not shown). For each patient, the score was then calculated by summing the weights corresponding to each variable. Thus, the score could range from 0 to 9 for a given patient. A cutoff was chosen according to the score's performance (Figure 1 ). Accuracy and positive and negative LR values by cutoff are presented in Table 4 . Patients with a score ≤3 were at low risk of Q fever pneumonia (Figure 2) , with a negative predictive value of 0.97 (95% CI, .90-1) and a sensitivity of 0.97 (95% CI, .89-1) ( Table 4) .
DISCUSSION
In the present study, 24.4% (95% CI, 17.1-31.8) of the CAP cases observed were caused by C. burnetii infection. This is the highest prevalence ever reported in the medical literature to our knowledge. In temperate-zone countries, the prevalence of acute Q fever in CAP patients ranges from 0% to 2.3%: 1.2% in the United Kingdom, 0.9% in the rest of Europe, and 2.3% in the Abbreviations: CI, confidence interval; CRP, C-reactive protein; OR, odds ratio. a Logistic regression analysis was performed for Q fever vs non-Q fever pneumonia. Weights are based on the β coefficients of the logistic regression and were calculated by rounding the model coefficients to the nearest whole integer. The weights rank the risk predictors in relative importance and dictate how one assigns integer points value for each predictor for a given patient. The assigned points are then summed to compute that individual's risk score. Figure 1 . Interquartile ranges of positive predictive value (PPV) (white box), negative predictive value (NPV) (gray box), sensitivity (white box), and specificity (gray box) according to the score predictive of Q fever pneumonia.
United States. The prevalence is lower even in hyperendemic areas. In Greece, the frequency of acute Q fever was 4.7% in a cohort of 3686 patients with atypical pneumonia [18] . In an Israeli study conducted in 1995 among 346 inpatients with CAP, 20 (5.8%) had Q fever pneumonia, and the authors concluded that Q fever was more endemic in their region than anywhere else [19] . A study in the Spanish Basque region reported a Q fever pneumonia prevalence of 18.8% in patients with CAP [20] . Recently, pneumonia was seen in very high numbers in an outbreak in the Netherlands and represented 61.5% of the 1009 Q fever cases identified [21] . However, some variations in cutoff titers (1:50 or 1:25 for IgM and 1:200 or 1:150 for IgG) of Q fever serology could explain some differences in the Q fever detection rates reported by other studies, independent of differences in geography or exposure. Nonetheless, the criteria used in the present study are the most specific, increasing confidence in the prevalence reported. Data on human Q fever are scarce in South America, probably owing to a lack of screening. For example, in Chile, no case was reported among 176 inpatients with CAP [22] , and Q fever accounted for only 0.3% of all pneumonia cases admitted to an emergency department in an Argentinian study [10] . Similarly, C. burnetii infection is not considered a tropical disease and perhaps is not described among febrile illnesses in travelers returning from tropical countries [23, 24] . For example, only 1 case was described in 2000 in Paris in a traveler returning from French Guiana [25] .
The present study population did not include outpatients from the emergency department and thereby may suffer from selection bias. Nevertheless, because studies on Q fever pneumonia are commonly hospital based, our results allow for easier comparison. Finally, as a retrospective study limitation, environmental and occupational exposures were not studied. A microbiological etiologic agent was found for 45.8% of the 131 patients, which is consistent with the findings of other large studies on CAP [22, 26, 27] . Indeed, such an agent is generally identified in 30%-74.3% of cases of CAP, depending on whether the study is community based or conducted in a hospital setting (hospitals, emergency departments, or intensive care units). The frequency of S. pneumoniae as a cause of CAP was low in this study, possibly owing to the lack of sensitivity of the rapid immunochromatographic test used for the detection of S. pneumoniae antigens in urine samples [27, 28] . Moreover, the rapid immunochromatographic test was not routinely used during this period and bronchoalveolar lavage was not performed in the absence of severe CAP symptoms.
Coxiella burnetii infection is diagnosed exclusively by serology in French Guiana and the bacterium has rarely been identified by polymerase chain reaction [15, 29] . In addition, its epidemiology seems different from what is observed in the main French territory, because it preferentially affects persons living in urban areas with unusual risk factors and shows a predominantly pulmonary form [15] .
The patient characteristics in this study were comparable to those previously published in the literature on Q fever pneumonia. Most were middle-aged men, which might be explained by a history of male-predominant occupational or environmental exposures [15] , and medical history [19] .
In the present study, the clinical picture of Q fever pneumonia was not very specific. Nevertheless, headache with arthromyalgia and chills was significantly more frequent in patients with C. burnetii CAP, which is consistent with the literature [30] . Radiological and biological presentations were also nonspecific. Furthermore, lymphopenia, thrombocytopenia, and renal failure, generally described as associated with Q fever, were not noteworthy here. One of the noticeable results in this study was the independent association of high CRP level and low leukocyte count with Q fever pneumonia. Leukocyte count was evaluated in most of the studies, whereas CRP level was less commonly measured [19, [29] [30] [31] .
The antibiotic guidelines of the French Infectious Diseases Society recommend amoxicillin (antipneumococcal) as the firstline treatment for CAP. However, since the occurrence of a fatal Q fever case in French Guiana [14] , an anti-C. burnetii antibiotic was systematically added to amoxicillin for the treatment of CAP in all primary healthcare centers and in Cayenne Hospital. Doxycycline was chosen because C. burnetii is resistant to β-lactams and aminoglycosides and has a heterogeneous susceptibility to macrolides and because fluoroquinolone resistance has been reported. In addition, the antimicrobial susceptibility of C. burnetii samples isolated in French Guiana is still unknown in the absence of polymerase chain reaction analysis or culture.
Moreover, C. burnetii infection diagnosis is obtained exclusively by serology in French Guiana and therefore is not available until several days after the start of antibiotherapy. Thus, it would be helpful to have a predictive score as a tool for the screening of Q fever pneumonia. The score described herein contained easy-touse clinical and biological parameters and could range from 0 to 9. More interestingly, this score could guide the first-line antibiotic choice. A score ≤3 may exclude C. burnetii as an etiologic agent of CAP with a negative predictive value of 97% (95% CI, .90-1), a sensitivity of 97% (95% CI, .89-1), and a negative LR of 0.1 (95% CI, 0-.39). In this case, the empirical antibiotic choice may be amoxicillin alone. Thus, it may play an important role in the decrease of unnecessary doxycycline prescriptions and the reduced risk of antimicrobial resistance and adverse effects. In our sample, doxycycline prescriptions would have been avoided for 28 patients (22.2%), and only 1 patient would not have been given doxycycline despite a retrospective Q fever diagnosis (Figure 1) . A score ≥4 could not exclude Q fever pneumonia. As a consequence, the combination of amoxicillin and doxycycline must be recommended as first-line empirical antibiotherapy in this case. Finally, this predictive score was useful to identify patients with low risk of Q fever pneumonia. Nevertheless, its validation is necessary in larger samples and in further prospective studies.
CONCLUSIONS
Q fever is an emerging disease in French Guiana, and pneumonia of variable severity is the major clinical presentation. To our knowledge, this study is the first to be conducted on Q fever pneumonia, which represented 24.4% of CAP inpatients. To help guide the empirical antibiotic choice for CAP treatment, a predictive score was built and could provide values from 0 to 9. Thus, a score ≤3 would allow physicians to use amoxicillin alone, excluding C. burnetii as an etiologic agent of CAP. In other cases (score ≥4), the combination of amoxicillin and doxycycline must be recommended. Further prospective studies are needed to validate this score in larger samples and to identify more precisely other risk factors for Q fever pneumonia.
Notes
